PROJECT

Projects

Summary of Investment Information

Project Number

52494

Company Name

Ingenix.AI Ltd.

Date SPI Disclosed

Dec 12, 2025

Country

Poland

Region

Europe

Projected Board Date

Jan 16, 2026

Environmental Category

C - No Impact

Status

Pending Signing

Last Updated Date

May 16, 2026

Department

Equity Portfolio Management

Industry

other

Previous Events

Approved : May 14, 2026

Sector

Other Health Services

Project Description

 IFC is considering an equity investment in Ingenix.AI LTD (Ingenix, or the Company) to support the development of an AI-platform for clinical drug development that helps pharmaceutical companies predict clinical trial outcomes, improve efficiency, and bring new treatments to patients faster.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation